AM-8553: a novel MDM2 inhibitor with a promising outlook for potential clinical development
- J Med Chem. 2012 Jun 14;55(11):4934-5. doi: 10.1021/jm3007068.
Affiliations
- 1. Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States.
PMID: 22624960
DOI: 10.1021/jm3007068